Canadian Cancer Society Breakthrough Team Grants: Transforming Low Survival Cancers – Letter of Intent

Well-being, Health and Biomedical Discovery


Academic Unit: inquire with unit

Memorial Deadline: May 2022 - Deadline to be confirmed

External Deadline: May 2022 - Deadline to be confirmed


The Canadian Cancer Society and partners are excited to announce the upcoming launch of a new funding opportunity, the CCS Breakthrough Team Grants: Transforming Low Survival Cancers. These grants will bring together the sharpest minds and research talent from across Canada and beyond, combining scientific and clinical expertise, with lived experience in a collaborative interdisciplinary environment. The goal is to develop and sustain a critical mass of researchers and resources, equipped to generate breakthroughs in survival and quality of life for cancers of unmet need.

These cancers are:

  • pancreas
  • oesophagus
  • brain
  • lung
  • liver
  • stomach

Anticipated Timelines:

  • Program Launch: May 2022
  • Letter of Intent Deadline: June 2022
  • Letter of Intent Workshop: late June 2022
  • Full Application Deadline: October 2022
  • Notice of Decision:  January 2023
  • Funding Start Date: January 2023
    *These timelines are estimates and subject to change.

This pre-announcement is a “call to action’” to give the research, clinical and patient communities an opportunity to start thinking creatively together about the best, the boldest, and the most innovative approaches towards transforming outcomes and reducing the number of Canadians dying from these six cancers.

For more information click here.

Funding Sources

Canadian Cancer Society

This opportunity was posted by: RGCS

Last modified: April 14, 2022